Since its introduction in 1977, balloon angioplasty has undergone major improvements but has persistent shortcomings: a 6.8-7.3% rate of abrupt closurel2 and a 17-49% rate of angiographic restenoSiS. [3] [4] [5] Balloon angioplasty has lower success rates in long lesions,4'6 calcified vessels,7 bifurcation lesions,8 saphenous vein graft stenoses,9 and ostial narrowings.10"' It is possible that some of these angiographic characteristics, which have been identified as relatively complex by the American College of Cardiology/American Heart Association (ACC/AHA) Task Force,12 may be handled more effectively by a procedure that removes atherosclerotic plaque such as excimer laser coronary angioplasty. Recent studies have reported that excimer laser-facilitated coronary angioplasty, in contrast to balloon angioplasty, is equally successful in treating simple and complex lesions. 13.14 In this study, we analyzed results in 200 consecutive patients who had 6 months of follow-up evaluation after excimer laser coronary angioplasty to define the determinants of acute success and restenosis with the new treatment.
Methods

Patient Enrollment
Beginning on May 8, 1989 , patients were enrolled for excimer laser-facilitated coronary angioplasty at Mount Sinai Medical Center, New York, or Brigham and Women's Hospital, Boston, if they had evidence of angina or provocable ischemia associated with lesions that were judged to be approachable with the laser catheter. Almost all patients could have been treated with balloon angioplasty but were enrolled in this study because of patient and physician preference. All patients were surgical candidates and had an ejection fraction >30.
We attempted to enroll patients with a broad representation of stenosis complexity, but not all lesion types were judged to be suitable for treatment with relatively stiff laser catheters. Using the ACC/AHA classification for balloon angioplasty,'2 we prospectively declared certain lesion types contraindicated for treatment with excimer laser coronary angioplasty. Whereas all type A lesions were judged to be suitable for treatment (length <10 mm, discrete, concentric, readily accessible, <450
angle, smooth contour, little or no calcification, less than totally occluded, not ostial, no major side branch involvement, absence of thrombus), several type B characteristics were contraindicated (angle >45°but <900, heavy calcification, and some thrombus present). Other type B lesions were believed to be amenable to laser angioplasty (length, 10-20 mm; eccentric, moderate tortuosity of proximal segment, irregular contour, total occlusion <3 months, ostial, bifurcation lesion requiring two guide wires, and moderate calcification). Only about half of the type C lesions were suitable for laser angioplasty (length >20 mm, total occlusion >3 months, degenerated vein graft, or inability to protect major side branches with a guide wire), but many type C lesions were contraindicated (excessive tortuosity of proximal segment, extremely angulated >900, or large thrombus present).
A total of 1,202 cases were screened for possible excimer laser angioplasty at the two hospitals. After discussion with referring physicians and review of diagnostic coronary arteriograms, 209 patients were formally asked to participate in the study. Three patients refused treatment with excimer laser angioplasty and underwent balloon angioplasty alone. Six patients had total occlusions that could not be recanalized with a guide wire, and no laser catheter was used. Thus, of 1,202 patients screened, 200 patients (16.6%) gave informed consent and underwent excimer laser angioplasty.
All patients were requested to have clinical follow-up with exercise treadmill testing at 1, 3, 6, and 12 months and to undergo follow-up angiography 6 
Restenosis
The angiographic restenosis rate of 48% that we observed after excimer laser-facilitated angioplasty is similar to the 40-49% restenosis rates recently reported for balloon angioplasty.4,5 Thus, there is no evidence to suggest that excimer laser has a lower overall restenosis rate than balloon angioplasty. In contrast to balloon angioplasty,26 however, excimer laser-facilitated angioplasty has a lower restenosis rate in saphenous vein grafts than in native vessels.
Restenosis after excimer laser-facilitated coronary angioplasty may be due to ascertainment bias, patient selection, or inadequate ablation of tissue. Symptomatic patients are more likely than asymptomatic patients to comply with the protocol requirement of a 6-month follow-up angiogram. Using the model of Califf et a127 and an estimated restenosis rate of 18% in asymptomatic patients who did not return for angiography, we would expect an angiographic restenosis rate of 42% if complete angiographic follow-up had been achieved. Patient selection may influence restenosis rates. We selected many patients for treatment with excimer laser coronary angioplasty because of the increased risk of restenosis reported after balloon angioplasty in the proximal left anterior descending coronary artery,28 29 in saphenous vein grafts,9 or after multiple restenosis events from prior angioplasty.30 Restenosis may be caused by inadequate tissue ablation31 despite the ability of excimer laser energy at 308 nm to vaporize atheromatous plaque32; it may be caused by mechanical dilatation, because only a fraction of the caused by deep arterial injury, which cannot always be avoided during excimer laser coronary angioplasty, as shown by the 14.5% incidence of dissection and 2.0% incidence of perforation. The mechanisms of inadequate tissue removal and deep arterial injury probably contribute to the similar restenosis rates after directional atherectomy. 33, 34 In this study, we observed that adjunctive balloon angioplasty did not increase the likelihood of restenosis compared with the use of excimer laser alone. This finding is in contrast to the conclusion of another study35 in which statistical significance was neither presented nor probably reached. None of the determinants of restenosis after balloon angioplasty,3 including lesion location9 28 29 or restenosis after prior angioplasty,30 predicted restenosis after excimer laser coronary angioplasty. The analysis presented here shows a trend toward a lower restenosis rate when the postprocedure lumen diameter is .2.5 mm. However, the number of observations is small and the confidence limits are correspondingly large.
Balloon Dilatation Failure
The third criterion for success of excimer laser coronary angioplasty deals with the indication of balloon dilatation failures. Because only anecdotal experience has been reported here ( Figure 1 ) and in another case report,36 no firm conclusions about the usefulness of excimer laser coronary angioplasty for this indication can be made.
Study Limitations
This is not a randomized comparison of excimer laser with balloon angioplasty; instead, we used relative risk analysis and comparisons with balloon angioplasty to identify where excimer laser angioplasty shows promise and where it should be avoided. The analysis is helpful in identifying high-risk lesions. However, the analysis is limited by the small number of statistically significant predictors in the cohort of 200 patients. Statistical power can be expected to increase with larger numbers of patients in a manner that depends on the square root of the number of patients. Other limitations of the study include incomplete angiographic follow-up, which is available for 83.1% of the patients. Fortunately, we have obtained clinical follow-up in 98.5% of patients and observed that 26 of the 29 patients who did not undergo follow-up angiography were asymptomatic. It is therefore unlikely that the angiographic restenosis rates are being underreported in this study. Other limitations of this study include the use of quantitative angiography in only a subgroup of patients. Basing the selection of patients for quantitative angiography on the suitability of adequate films ensured that the subgroup of patients was representative of the overall population. The quantitative angiography was useful to show that visual assessment is accurate after laser dilatation, after balloon angioplasty, and at follow-up. Another limitation is that a core angiography laboratory has not been used. Instead, two different quantitative angiography systems have been used. However, both systems have been previously validated,19-21 and it is unlikely that quantitative analysis for all patients would alter the conclucatheter tip is composed of optical fibers; or it may be sions of the study.
Summary
Excimer laser-facilitated coronary angioplasty shows promise for lesions that are long, ostial in position, or located in degenerated saphenous vein grafts. To establish excimer laser coronary angioplasty as a useful adjunct to balloon angioplasty, a randomized trial must be conducted to compare the acute success of excimer laser-facilitated treatment with balloon angioplasty alone for selected lesion types.
